Petco Health and Wellness Company, Inc. WOOF

Petco Health and Wellness Company, Inc. (WOOF) is highlighted as a Zacks Rank #1 buy, with the current-year earnings consensus up 26.3% over the last 60 days; its PEG ratio is 0.87, lower than the industry’s 2.14, and it carries a Growth Score of B. Five Below (FIVE) is also named a Zacks Rank #1, with 15.2% earnings growth, a PEG of 0.88, and Growth Score B. Oscar Health (OSCR) shows the strongest momentum among the trio: earnings estimates up 210.2%, a PEG of 0.34, and Growth Score A. The piece points to a complete list of today’s Zacks #1 Rank stocks and offers a free report link for each name. Rising consensus estimates and a top-rated buy signal can buoy near-term sentiment but do not indicate a fundamental shift in Petco's business.

Chewy raised its fiscal 2026 net sales guidance to $13.46-$13.57 billion (6.8%-7.7% growth) with organic growth of 5.5%-6.3%, aided by SmartPak and Modern Animal contributions. Autoship sales climbed 9.3% to $2.82 billion and represented 84.6% of Q2 net sales; active customers rose 3.8% to 21.7 million. Management lifted the low end of adjusted EBITDA margin guidance to 6.7%-6.8%, signaling about $912 million in adjusted EBITDA at the midpoint. The second-quarter margin improved as adjusted SG&A fell to 18.4% of sales, supported by fulfillment automation and lower variable costs. AI initiatives are expected to generate cost savings in the low tens of millions in 2026 and about $50 million annually in 2027, with Kai resolving roughly 30% of chats via self-service. Q2 net sales rose 7.3% to $3.33 billion; adjusted EBITDA rose 23.7% to $226.7 million; EPS was $0.36, up 9.1%. Some gains are timing-related amid softer discretionary spending. Chewy’s upgraded 2026 outlook and AI-driven efficiency could moderately influence market sentiment around pet e-commerce dynamics, affecting peers like Petco but with balanced risk from consumer softness.

Chewy is leaning on autoship demand and expanding health services to drive growth and profitability. In fiscal Q2 2026, autoship sales rose 9.3% year over year and represented 84.6% of net sales, with active customers at 21.7 million and net sales per active customer of $602. Chewy Vet Care, Modern Animal, and SmartPool delivered triple-digit revenue growth, expanding cross-sell opportunities beyond merchandise and leveraging telehealth. Profitability improved as adjusted EBITDA rose 23.7% to $226.7 million and margins expanded to 6.8%, aided by about $15 million of discrete benefits and roughly $10 million of timing-related items. EPS was 36 cents, roughly in line with expectations. The stock trades around 19.4x forward earnings amid softer discretionary pet spending and competitive pressures; Petco Health and Wellness (WOOF) is cited as a peer, highlighting the competitive landscape. Chewy's expanding autoship and health services imply intensified competition and potential margin pressure for Petco.

Chewy shares have fallen 24.9% in the last four weeks as investors weigh whether improving operating metrics can offset softer consumer demand and margin normalization. The drop has driven CHWY's forward multiple toward a five-year low even as autoship sales, active customers, and per-customer spend support the recurring-revenue model. In Q2 fiscal 2026, Chewy posted net sales of $3.33 billion (+7.3% YoY) and adjusted EBITDA of $226.7 million, with growth drivers like Autoship up 9.3% and active customers at 21.7 million. Yet management warned gross margin would likely dip modestly in Q3 as timing-related benefits normalize. The report notes rival Petco (WOOF) delivered about $1.5 billion in Q2 net sales, up 0.05% with flat comps, underscoring a mixed backdrop across the sector. Zacks assigns CHWY a Sell rating. Chewy's earnings revisions and margin normalization amid softer discretionary demand could temper Petco's near-term sentiment and valuation.

Petco Health & Wellness (WOOF) is favored on value metrics over Ulta Beauty (ULTA). WOOF has a #1 Strong Buy Zacks Rank, while ULTA is #3 Hold. Valuation paths show WOOF with a forward P/E of 9.96, PEG 0.90, and P/B 0.64; ULTA posts a forward P/E of 19.14, PEG 1.66, and P/B 8.96. These lead to WOOF earning a Value grade of A and ULTA a C. Zacks notes improving earnings revisions for WOOF, suggesting a brighter near-term earnings outlook. Overall, the pairing of favorable rank and stronger value metrics positions WOOF as the more attractive option for value-focused investors and may influence sentiment and expectations around the stock. Lower forward valuations and a Strong Buy rank imply a modest positive tilt in sentiment and earnings prospects for WOOF.

Petco (WOOF) stock appears undervalued after recent declines, with metrics signaling potential rebound opportunity for bottom fishing investors amid ongoing retail sector pressures. Analysis points to possible short-term sentiment shift from valuation signals but no fundamental trajectory change for the company.

Petco (WOOF) Q2 2026 earnings call transcript details quarterly financial performance, management commentary on operations, and outlook. Earnings releases and guidance directly move valuations and investor sentiment for Petco.

Petco Health and Wellness Company stock trades at valuations unchanged from its pre-restructuring era despite operational shifts and new initiatives. Persistent old-style valuation limits upside in market perception and share performance without fundamental re-rating.

Petco Health and Wellness Company, Inc. (WOOF) held its Q2 2026 earnings call covering financial results and company outlook. Earnings call releases core financial metrics and guidance that typically drive stock movement and investor views.

Petco Health and Wellness Company posted Q2 profitability gains despite flat sales through emphasis on loyalty programs and category expansion. Profitability gains alongside loyalty and expansion focus indicate moderate influence on financial performance and positioning.

Petco Health and Wellness Company exceeded Q2 earnings estimates, prompting a rise in its shares. Q2 earnings beat triggered share price increase and positive market reaction for WOOF.

Petco Health and Wellness reports positive comparable sales in its Q2 2026 earnings call highlights. Positive comps signal improved sales trends that may lift near-term financial results and sentiment.

Petco Health and Wellness Company (WOOF) reported Q2 financial results during its earnings call, covering revenue, margins, same-store sales, and updated guidance on pet care demand and cost management. Q2 earnings release and guidance directly inform near-term revenue and margin expectations for WOOF.

Petco Health and Wellness Company, Inc. (WOOF) exceeded Q2 CY2026 EPS forecasts, triggering a 10.3% stock price increase. Single-quarter EPS beat lifts near-term sentiment but leaves core operations and long-term trajectory unchanged.

Petco Health and Wellness Company, Inc. reported second quarter 2026 results. Quarterly results update financials and may shift near-term sentiment without major strategic changes.

Chewy acquires Modern Animal to strengthen its pet healthcare platform. Chewy acquisition intensifies competition against Petco in pet healthcare services.

Chewy stock falls 45% over three months, leaving investors to decide whether to hold, sell or buy the dip in the pet retail sector. Chewy's sharp decline signals sector-wide pressures that can moderately shift competitive dynamics and investor sentiment toward Petco.

Chewy expands into veterinary services, broadening its addressable market and increasing competition in pet care. Competitor expansion into veterinary services raises market pressure on Petco operations.

Petco Health and Wellness reported Q1 results; its earnings call featured five primary analyst questions on performance, strategy, and outlook. Q1 earnings call and analyst questions may moderately shape near-term investor views on operations and guidance.

Petco faces tough competition but shows building momentum. Tough competition creates risks while momentum signals moderate effects on operations and positioning.

Petco Health and Wellness investment narrative for WOOF is changing heading into 2026. Evolving WOOF investment outlook points to moderate influence on future trajectory.

Petco reports flat Q1 sales, maintains margin discipline, expands services amid market caution. Flat sales offset by margin control and service growth point to moderate effects on near-term results.

Petco shares fell after Q1 loss widened despite sales beat. Mixed Q1 results with deeper loss drove immediate share decline and short-term negative sentiment.

Petco Health and Wellness Co Inc reports Q1 2026 earnings call highlights focused on navigating modest conditions. Earnings highlights describe modest operational adjustments likely to produce moderate influence on performance.

Petco Health and Wellness Company reported Q1 financial results and strategic updates during its earnings call, covering revenue, margins, store performance, and forward guidance for WOOF. Quarterly earnings call and guidance directly shape near-term stock valuation and investor positioning for WOOF.

Petco Health and Wellness Company, Inc. (WOOF) held its Q1 2026 earnings call. Routine earnings call delivers financial results and guidance with moderate effect on near-term stock sentiment.

Petco exceeded Q1 CY2026 sales expectations but its stock declined 10.8%. Earnings beat paired with sharp stock drop points to investor concerns over future results.

Petco Health and Wellness Company reported first quarter 2026 results. Quarterly results disclosure typically produces moderate short-term share price movement without altering long-term strategy.

Petco (WOOF) will report earnings tomorrow. The report covers expected financial results that may affect stock movement and investor views. Earnings releases often drive notable stock price shifts and alter near-term market sentiment for the company.

Petco Health and Wellness Company, Inc. (WOOF) possesses one of America’s strongest brands yet trades as one of the market’s worst-performing stocks, highlighting a sharp disconnect between brand value and equity performance. Persistent poor stock performance despite brand strength risks sustained negative investor sentiment and pressure on WOOF’s valuation.